Zhende Medical Co., Ltd. Stock

Equities

603301

CNE100003J31

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 18:00:00 2024-04-28 EDT 5-day change 1st Jan Change
20.9 CNY +1.36% Intraday chart for Zhende Medical Co., Ltd. +7.18% -14.69%

Financials

Sales 2024 * 4.74B 655M 895M Sales 2025 * 5.63B 779M 1.06B Capitalization 5.52B 764M 1.04B
Net income 2024 * 480M 66.38M 90.67M Net income 2025 * 610M 84.36M 115M EV / Sales 2024 * 1.17 x
Net cash position 2024 * - 0 0 Net cash position 2025 * - 0 0 EV / Sales 2025 * 0.98 x
P/E ratio 2024 *
11.5 x
P/E ratio 2025 *
9.09 x
Employees 8,027
Yield 2024 *
2.15%
Yield 2025 *
2.78%
Free-Float 38%
More Fundamentals * Assessed data
Dynamic Chart
Zhende Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhende Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhende Medical Co., Ltd.(XSSC:603301) added to S&P Global BMI Index CI
Zhende Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Zhende Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhende Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Zhende Medical Co., Ltd.(XSSC:603301) dropped from S&P Global BMI Index CI
Zhende Medical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tranche Update on Zhende Medical Co., Ltd.'s Equity Buyback Plan announced on September 30, 2022. CI
Zhende Medical Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares. CI
Zhende Medical Co., Ltd. authorizes a Buyback Plan. CI
Zhende Medical Co., Ltd. announced that it has received CNY 976.452074 million in funding from Zhejiang Zhende Holding Co., Ltd., Xuchang Zhende Landscaping Engineering Co., Ltd. CI
Xuchang Zhende Surgical Dressing Co.,Ltd announced that it has received CNY 976.452074 million in funding from Zhende Medical Co., Ltd., Xuchang Zhende Landscaping Engineering Co., Ltd., and another investor CI
Zhende Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Zhende Medical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 day+1.36%
1 week+7.18%
Current month+3.57%
1 month+3.57%
3 months+2.80%
6 months-21.01%
Current year-14.69%
More quotes
1 week
19.94
Extreme 19.94
21.08
1 month
18.83
Extreme 18.83
21.08
Current year
15.68
Extreme 15.68
25.38
1 year
15.68
Extreme 15.68
36.19
3 years
15.68
Extreme 15.68
59.00
5 years
13.09
Extreme 13.0857
106.11
10 years
13.09
Extreme 13.0857
106.11
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 94-07-31
Director of Finance/CFO 48 97-06-30
Director/Board Member 50 96-02-29
Members of the board TitleAgeSince
Director/Board Member 61 22-07-24
Director/Board Member 73 16-07-06
Director/Board Member 44 22-07-24
More insiders
Date Price Change Volume
24-04-29 20.9 +1.36% 1,717,900
24-04-26 20.62 +0.10% 1,491,324
24-04-25 20.6 +0.54% 917,880
24-04-24 20.49 +1.89% 1,284,898
24-04-23 20.11 +3.13% 1,558,340

End-of-day quote Shanghai S.E., April 28, 2024

More quotes
Zhende Medical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of medical dressing products. The Company’s main products include modern wound dressings, surgical control products, traditional wound care products and pressure treatment and fixation products. The Company mainly distributes its products in domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
20.9 CNY
Average target price
28 CNY
Spread / Average Target
+33.95%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603301 Stock